GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (FRA:8GN) » Definitions » Price-to-Owner-Earnings

Cessatech AS (FRA:8GN) Price-to-Owner-Earnings : (As of Jan. 18, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Cessatech AS Price-to-Owner-Earnings?

As of today (2025-01-18), Cessatech AS's share price is €1.42. Cessatech AS does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Cessatech AS's Price-to-Owner-Earnings or its related term are showing as below:


FRA:8GN's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 29.67
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-01-18), Cessatech AS's share price is €1.42. Cessatech AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.16. Therefore, Cessatech AS's PE Ratio (TTM) for today is At Loss.

As of today (2025-01-18), Cessatech AS's share price is €1.42. Cessatech AS's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.16. Therefore, Cessatech AS's PE Ratio without NRI for today is At Loss.


Cessatech AS Price-to-Owner-Earnings Historical Data

The historical data trend for Cessatech AS's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Price-to-Owner-Earnings Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - -

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cessatech AS's Price-to-Owner-Earnings

For the Biotechnology subindustry, Cessatech AS's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cessatech AS's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cessatech AS's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cessatech AS's Price-to-Owner-Earnings falls into.



Cessatech AS Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cessatech AS's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1.42/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cessatech AS  (FRA:8GN) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Cessatech AS Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cessatech AS's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Cessatech AS Business Description

Traded in Other Exchanges
Address
Kanonbadsvej 2, Copenhagen, DNK, 1437
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.

Cessatech AS Headlines

No Headlines